Carl Zeiss Meditec AG (LON:0DHC)

Market Cap	3.85B
Revenue (ttm)	1.81B
Net Income (ttm)	130.40M
Shares Out	n/a
EPS (ttm)	1.48
PE Ratio	29.55
Forward PE	23.31
Dividend	0.50 (0.98%)
Ex-Dividend Date	Mar 27, 2025

Volume	581
Average Volume	5,000
Open	50.64
Previous Close	51.20
Day's Range	50.45 - 51.55
52-Week Range	44.28 - 72.10
Beta	1.23
RSI	32.73
Earnings Date	Aug 7, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DHC

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.

Financial numbers in EUR